Project Grant R21AI191580
Award Date 9/3/25
Completion Date 8/31/27
Dollars Obligated $227K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- This Project Grant award of $962,973.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate a comprehensive curriculum on HIV prevention and implementation science for pharmacy schools in the southern United States. The project, titled "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic through Collaboration with Pharmacy Schools," will be...
- This federal Project Grant award of $1,066,077 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant will fund a Type 3 hybrid effectiveness-implementation study to evaluate the "PrEP & Soccer" intervention delivered through CVS pharmacy locations in Miami-Dade, Florida. The intervention aims to increase PrEP knowledge and initial PrEP appointment attendance among...
- The University of Chicago received a $126,435 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to pilot the implementation of electronic patient-reported sexual health data into electronic medical records (EMRs) to identify individuals who would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. The project, titled "INFOHIV: Clinical Informatics for Optimizing HIV Prevention and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $128,451 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the University of Alabama at Birmingham (UAB). The grant, titled "Structural Basis for HIV-1 Rev Nucleocytoplasmic Trafficking," seeks to decipher how the HIV-1 Rev protein is recognized, bound, and trafficked through the nuclear pore complex by the host nuclear transport machinery. The research aims...
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Colorado State University a $340,408 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and validate an assay for precision antiretroviral therapy to combat drug resistance in HIV patients. The key products and services to be delivered under this award include: Improving the throughput and capacity of an existing infectivity assay using proviral constructs with an H2B-mRFP...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $244,328 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The award, which began on January 6, 2025 and will be completed by December 31, 2026, supports research on the impact of in utero HIV and antiretroviral exposure on the placenta and birth weight. The study will...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,414,502 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct research on assessing the variability in antiretroviral (ARV) drug penetration within tissues as a potential factor contributing to the persistence of HIV during treatment. The research aims to leverage advanced imaging techniques,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $721,721 to the University of California, Los Angeles (UCLA) to establish the UCLA RAPID, RIGOROUS, RELEVANT IMPLEMENTATION SCIENCE HUB. This five-year grant, running from August 1, 2025 to July 31, 2030, will leverage implementation science to enhance the translation of HIV research into routine clinical practice and improve population health outcomes. Key objectives include providing technical...
- The National Institute of Mental Health (NIMH) awarded a $790,198 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Alabama at Birmingham (UAB) for the "PROTECT AL: PREP OPTIMIZATION THROUGH ENHANCED CONTINUUM TRACKING" project. The grant, awarded on September 18, 2025, aims to develop effective interventions to scale up and sustain HIV pre-exposure prophylaxis (PrEP) utilization in the Southern United States, a region disproportionately...